TESTICULAR CANCER METASTATIC

TESTICULAR CANCER METASTATIC was reported 86 times

These drug classes are most commonly taken by patients reporting TESTICULAR CANCER METASTATIC:

# Drug Count
0 Platinum-based Drug [EPC] 14
1 Corticosteroid [EPC] 11
2 Atypical Antipsychotic [EPC] 8
3 Topoisomerase Inhibitor [EPC] 8
4 Purine Antimetabolite [EPC] 7
5 Aldosterone Antagonist [EPC] 6
6 Xanthine Oxidase Inhibitor [EPC] 6
7 Estrogen [EPC] 5
8 Alkylating Drug [EPC] 4
9 Nonsteroidal Anti-inflammatory Drug [EPC] 4
10 Tumor Necrosis Factor Blocker [EPC] 4
11 Leukocyte Growth Factor [EPC] 3
12 Microtubule Inhibitor [EPC] 3
13 Osmotic Laxative [EPC] 3
14 Proton Pump Inhibitor [EPC] 3
15 Serotonin-3 Receptor Antagonist [EPC] 3
16 Aminosalicylate [EPC] 2
17 Folate Analog Metabolic Inhibitor [EPC] 2
18 Interferon beta [EPC] 2
19 Janus Kinase Inhibitor [EPC] 2
20 Nucleoside Metabolic Inhibitor [EPC] 2
21 Opioid Agonist [EPC] 2
22 Vitamin C [EPC] 2
23 Aluminum Complex [EPC] 1
24 Androgen Receptor Inhibitor [EPC] 1
25 Antimycobacterial [EPC] 1
26 Asparagine-specific Enzyme [EPC] 1
27 Benzodiazepine [EPC] 1
28 CD20-directed Cytolytic Antibody [EPC] 1
29 Cardiac Glycoside [EPC] 1
30 GLP-1 Receptor Agonist [EPC] 1
31 Histamine-2 Receptor Antagonist [EPC] 1
32 Insulin Analog [EPC] 1
33 Integrin Receptor Antagonist [EPC] 1
34 Interleukin-12 Antagonist [EPC] 1
35 Interleukin-23 Antagonist [EPC] 1
36 Loop Diuretic [EPC] 1
37 Muscle Relaxant [EPC] 1
38 Phosphodiesterase 4 Inhibitor [EPC] 1
39 Platelet Aggregation Inhibitor [EPC] 1
40 Potassium Salt [EPC] 1
41 Prostaglandin E1 Analog [EPC] 1
42 Proteasome Inhibitor [EPC] 1
43 Stimulant Laxative [EPC] 1
44 Tetracycline-class Drug [EPC] 1
45 Thiazide Diuretic [EPC] 1
46 Vitamin B12 [EPC] 1
47 Vitamin D [EPC] 1